Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda
- PMID: 35721671
- PMCID: PMC9199528
- DOI: 10.2147/CEG.S356977
Etiology, Clinical Presentations, and Short-Term Treatment Outcomes of Extrahepatic Obstructive Jaundice in South-Western Uganda
Abstract
Background: The diagnosis of extrahepatic obstructive jaundice (EHOJ) remains a challenge and is often made late in low-resource settings. Systematic data are limited on the etiology and prognosis of patients with obstructive jaundice in Uganda. The objective of this study was to determine the etiology, clinical presentations, and short-term treatment outcomes of patients managed for EHOJ at Mbarara Regional Referral Hospital (MRRH) in south-western Uganda.
Methods: Between September 2019 and May 2020, we prospectively enrolled a cohort of patients who presented with EHOJ at MRRH. A pretested, semi-structured data collection tool was used to abstract data from both the study participants and their files.
Results: A total of 72 patients, 42 (58.3%) of whom were male with a median age of 56 (range of 2 months to 95 years) were studied. Forty-two (58.3%) participants had malignancies: Pancreatic head tumors 20 (27.8%), cholangiocarcinoma 13 (18.1%), duodenal cancers 5 (6.94%), and gall bladder cancer 4 (5.6%). The remaining 30 (41.7%) participants had benign etiologies: choledocholithiasis 10 (13.9%), biliary atresia 7 (9.7%), pancreatic pseudo cyst 6 (8.3%), Mirizzi syndrome 5 (6.9%) and 1 (1.4%) each of chronic pancreatitis and choledochal cyst. Sixty-seven (93.1%) patients presented with right upper quadrant tenderness, 65 (90.3%) abdominal pain and 55 (76.3%) clay-colored stool. Cholecystectomy 11 (25.6%) and cholecystojejunostomy + jejunojejunostomy 8 (18.6%) were the commonest procedures performed. Twelve (17.0%) of cases received chemotherapy (epirubicin/cisplatin/capecitabine) for pancreatic head tumors and (gemcitabine/oxaliplatine) for cholangiocarcinoma. Mortality rate was 29.2% in the study, of which malignancy carried the highest mortality 20 (95.24%).
Conclusion: Malignancy was the main cause of EHOJ observed in more than half of the patients. Interventions aimed at early recognition and appropriate referral are key in this population to improve outcomes.
Keywords: Uganda; benign obstructive jaundice; malignant obstructive jaundice.
© 2022 Odongo et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
References
-
- Olatoke S, Agodirin S, Adenuga A, Adeyeye A, Rahman G. Management of obstructive jaundice: experience in a North Central Nigerian Hospital. Trop J Health Sci. 2018;25:21–25.
-
- Gelan EA, Abdlhadi M, Bekele M, Tsehay A, Lemmu B. A retrospective analysis of etiological spectrum, clinical presentation, treatment and outcome of extra hepatic biliary tree obstruction at a tertiary teaching hospital in Addis Ababa, Ethiopia. Ethiop Med J. 2019;201757.
-
- Gupta P, Gupta J, Kumar-m P. Imaging in obstructive jaundice: what a radiologist needs to know before doing a percutaneous transhepatic biliary drainage. J Clin Interv Radiol ISVIR. 2020;4:31–37.
-
- Jarnagin WR, Shoup M. Surgical management of cholangiocarcinoma. In: Seminars in Liver Disease. Copyright© 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New; 2004:189–199. - PubMed
LinkOut - more resources
Full Text Sources
